Abbott Laboratories (ABT) — 8-K Filings
All 8-K filings from Abbott Laboratories. Browse 18 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (18)
- 8-K Filing — Apr 16, 2026
-
Abbott Labs Files 8-K on Officer Changes & Filings
— Dec 12, 2025 Risk: low
Abbott Laboratories filed an 8-K on December 12, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment o - 8-K Filing — Nov 21, 2025
- 8-K Filing — Nov 20, 2025
-
Abbott Labs Files 8-K on Financials
— Oct 15, 2025 Risk: low
On October 15, 2025, Abbott Laboratories filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well -
Abbott Labs Files 8-K on Operations and Financials
— Jul 17, 2025 Risk: low
Abbott Laboratories filed an 8-K on July 17, 2025, reporting on its results of operations and financial condition, and filing financial statements and exhibits. -
Abbott Labs Reports Director and Officer Changes
— May 1, 2025 Risk: low
Abbott Laboratories filed an 8-K on May 1, 2025, reporting changes effective April 25, 2025. The filing pertains to the departure of directors, election of dire -
Abbott Labs Files 8-K on Security Holder Vote Matters
— Apr 28, 2025 Risk: low
Abbott Laboratories filed an 8-K report on April 28, 2025, indicating a submission of matters to a vote of security holders. The report pertains to events occur -
Abbott Labs Files 8-K on Financials
— Apr 16, 2025 Risk: low
Abbott Laboratories filed an 8-K on April 16, 2025, reporting on its results of operations and financial condition, and providing financial statements and exhib -
Abbott Labs Files 8-K on Financials
— Jan 22, 2025 Risk: low
Abbott Laboratories filed an 8-K on January 22, 2025, reporting on its results of operations and financial condition. The filing includes financial statements a -
Abbott Labs Announces Executive and Director Changes
— Nov 15, 2024 Risk: medium
Abbott Laboratories announced on November 12, 2024, changes in its executive team. Specifically, the company reported the departure of certain officers and the -
Abbott Labs Files 8-K on Operations and Financials
— Oct 16, 2024 Risk: low
Abbott Laboratories filed an 8-K on October 16, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibi -
Abbott Labs Files 8-K on Operations and Financials
— Jul 18, 2024 Risk: low
Abbott Laboratories filed an 8-K on July 18, 2024, to report on its results of operations and financial condition, as well as to file financial statements and e -
Abbott Labs Reports Officer and Director Changes
— May 1, 2024 Risk: low
Abbott Laboratories filed an 8-K on May 1, 2024, reporting changes effective April 26, 2024. The filing pertains to the departure of directors or certain office -
Abbott Labs Files 8-K on Shareholder Votes
— Apr 29, 2024 Risk: low
Abbott Laboratories (ABT) filed an 8-K on April 29, 2024, reporting on matters submitted to a vote of security holders as of April 26, 2024. The filing details -
Abbott Labs Files 8-K on Q1 Financials
— Apr 17, 2024 Risk: low
Abbott Laboratories filed an 8-K on April 17, 2024, reporting on its results of operations and financial condition. The filing covers the period from January 1, -
Abbott Labs Reports Material Agreements & New Financial Obligation
— Jan 29, 2024
Abbott Laboratories filed an 8-K on January 29, 2024, indicating an "Entry into a Material Definitive Agreement," "Termination of a Material Definitive Agreemen -
Abbott Labs Files 8-K on Financial Results & Operations
— Jan 24, 2024
Abbott Laboratories filed an 8-K on January 24, 2024, to report its results of operations and financial condition, as well as related financial statements and e
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX